BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 9, 2009
View Archived Issues
Screening study shows reduced prostate cancer risk with finasteride across PSA levels
Read More
Novel series of hypoxia-activated compounds identified by Threshold Pharmaceuticals
Read More
Array BioPharma patent claims new tyrosine kinase inhibitors for cancer treatment
Read More
Schering-Plough patent discloses novel gamma-secretase modulators for the treatment of AD
Read More
New compounds for the treatment of hepatitis C claimed in Schering-Plough patents
Read More
New liver X receptor ligands under study at Organon for atherosclerosis
Read More
New myocardial imaging tracer shows safety and good biodistribution profile in phase I trial
Read More
Novel inhibitors of Abeta calcium channel activity confer neuroprotection in vitro
Read More
Alkermes advances proprietary pipeline
Read More
Avineuro commences phase I AVN-101 study for Alzheimer's disease
Read More
Cancer Therapy & Research Center and OncoVista collaborate on OVI-117
Read More
Somaxon provides update on NDA for Silenor for insomnia
Read More
GLYC-101 achieves accelerated wound closure based on interim analysis
Read More
Gen-Probe acquires Tepnel Life Sciences
Read More
BioWa licenses Potelligent Technology to sanofi-aventis
Read More
Cordex Pharma and BG Medicine collaborate on phase II trial of CDP-1050
Read More
Array BioPharma initiates clinical trial for ARRY-403 in type 2 diabetes
Read More
Amarin's MAA for AMR-101 in Huntington's disease accepted for review
Read More
IntelGenx and Cary file NDA for antidepressant, CPI-300
Read More
Cetuximab with chemotherapy as first-line treatment for metastatic colorectal cancer
Read More
Allergy signs distribution agreement with Nycomed Canada for Pollinex Quattro
Read More
Relaxin shows promising results in phase II study in acute heart failure
Read More
Coartem receives FDA approval for malaria in the U.S.
Read More
DSMB recommends continuation of phase III Iluvien studies
Read More
KAI initiates third phase IIa KAI-1678 trial for neuropathic pain
Read More
Genentech voluntarily withdraws Raptiva from the U.S. market
Read More
